Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comment
. 2013 Jun;57(6):2906.
doi: 10.1128/AAC.00592-13.

Reply to "What types of Candida infections should be included when evaluating breakthrough infections during posaconazole prophylaxis?"

Michael J Dolton, Andrew J McLachlan
Comment

Reply to "What types of Candida infections should be included when evaluating breakthrough infections during posaconazole prophylaxis?"

Michael J Dolton et al. Antimicrob Agents Chemother. 2013 Jun.
No abstract available

PubMed Disclaimer

Comment on

References

    1. Blennow O, Kalin M. 2013. What types of Candida infections should be included when evaluating breakthrough infections during posaconazole prophylaxis? Antimicrob. Agents Chemother. 57:2905. - PMC - PubMed
    1. Dolton MJ, Ray JE, Chen SC, Ng K, Pont L, McLachlan AJ. 2012. Multicenter study of posaconazole therapeutic drug monitoring: exposure-response relationship and factors affecting concentration. Antimicrob. Agents Chemother. 56:5503–5510 - PMC - PubMed
    1. De Pauw B, Walsh TJ, Donnelly JP, Stevens DA, Edwards JE, Calandra T, Pappas PG, Maertens J, Lortholary O, Kauffman CA, Denning DW, Patterson TF, Mashmeyer G, Bille J, Dismukes DE, Herbrecht R, Hope WW, Kibbler CC, Kullberg BJ, Marr KA, Muñoz P, Odds FC, Perfect JR, Restrepo A, Ruhnke M, Segal BH, Sobel JD, Sorrell TC, Viscoli C, Wingard JR, Zaoutis T, Bennet JE. 2008. Revised definitions of invasive fungal disease from the European Organization for Research and Treatment of Cancer/Invasive Fungal Infections Cooperative Group and the National Institute of Allergy and Infectious Diseases Mycoses Study Group (EORTC/MSG) Consensus Group. Clin. Infect. Dis. 46:1813–1821 - PMC - PubMed

LinkOut - more resources